HIRUDOID

This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Finland, Hong Kong, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom

Active ingredients

The drug HIRUDOID contains one active pharmaceutical ingredient (API):

1 Heparinoid

Heparinoid is recognised as having: a weak inhibitory effect on PGE2 synthesis and an indirect effect on LTB4 production (based on in vitro studies), anti-coagulant activity (as a heparinoid), thrombolytic activity (through potentiation of urokinase activity), anti-exudatory activity (through inhibition of hyaluronidase).

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
HIRUDOID Cream	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C05BA01	Organo-heparinoid	C Cardiovascular system → C05 Vasoprotectives → C05B Antivaricose therapy → C05BA Heparins or heparinoids for topical use
Discover more medicines within C05BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 530413040008803, 530413040008903, 530413040009003, 530413040009103, 530413040009203, 530417040013903, 530417040014003
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 363571212, 369521213, 435-MEE-0914
Country: EE	Ravimiamet	Identifier(s): 1029237, 1029248, 1071762, 1071773
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 098347, 098358, 098370, 098381, 470831, 470930
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 31572, 31586
Country: HK	Department of Health Drug Office	Identifier(s): 07059, 39212, 57432
Country: JP	医薬品医療機器総合機構	Identifier(s): 2649950M1143, 3339950M1137, 3339950N1035, 3339950R1177
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1009113, 1009114, 1009115, 1010190
Country: NL	Z-Index G-Standaard	Identifier(s): 12124427, 12124435
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 1112
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 439
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100029058, 100249328, 100293134, 100304903, 100306523, 100348510, 100348585, 100359206, 100385439, 100400475, 100426776
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W01841001, W01842001
Country: SG	Health Sciences Authority	Identifier(s): 04236P, 04421P, 14339P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699527341523, 8699527351546